Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 489 of 5804
-
Engineered cord blood cells take aim at stubborn colorectal cancer
Disease control Recruiting nowTo find the highest and/or recommended dose of TROP2-CAR-NK cells combined with cetuximab in participants with MRD CRC.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New antiviral pill aims to keep High-Risk COVID patients out of hospital
Disease control Recruiting nowResearchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. However, people with certain health conditions or other factors have a high risk (chance) of getting severely ill from COVID-…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a peptide supercharge COVID-19 vaccines for seniors?
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this research is to learn more about ZADAXIN® (trade name; thymalfasin generic; Ta1 for short) and determine if Ta1 has any benefit in increasing the immune response to the COVID-19 vaccine. Ta1 has been shown to stimulate the immune system to fight infections. This …
Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 18, 2026 00:00 UTC
-
New combo therapy targets Hard-to-Treat lymphoma
Disease control Recruiting nowThis phase II trial studies the side effects of acalabrutinib, obinutuzumab, and glofitamab and how well they work together for treating patients with mantle cell lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment …
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Cord blood cells take on lymphoma: new hope for relapsed patients
Disease control Recruiting nowTo study the safety and effectiveness of cord blood-derived IL-10/IL-15 CD19-CAR NK in patients with B-cell non-Hodgkin's lymphoma
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New stent aims to save lives from aortic tears
Disease control OngoingStudy Title: "Multi-center Real-world Study on Straight Tubular Thoracic Aortic Perforated Stent-Graft System for Treating Thoracic Aortic Dissection" Purpose: This study aims to evaluate the effectiveness of the Talos stent-graft system, a new device designed to treat aortic …
Sponsor: Qingyou Meng • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI-Powered program aims to prevent suicide in native american health systems
Prevention ENROLLING_BY_INVITATIONThe goal of this research is to test a systems-level suicide prevention strategy, Native-RISE (Risk Identification for Suicide and Enhanced care), that combines predictive analytics and brief contact interventions (BCIs) to reduce suicide in health systems serving Native American…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Combination therapy aims to keep leukemia in check after transplant
Disease control Recruiting nowThis prospective study will be conducted in high-risk B-ALL patients post-allo-HSCT. We propose to investigate the safety and therapeutic efficacy of blinatumomab plus low-dose DLI maintenance therapy, with the ultimate goal of enhancing long-term survival outcomes.
Phase: PHASE1 • Sponsor: Liping Dou • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Second chance at breast preservation: new study tests repeat radiation
Disease control Recruiting nowThis study explores whether recurrent breast cancer can be safely treated with breast-conserving surgery and repeated radiation therapy in cases where patients have previously undergone radiation. Traditionally, recurrent breast cancer has been treated by removing the entire brea…
Phase: NA • Sponsor: Turku University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Atacicept's Long-Term promise for kidney disease
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to collect long-term safety and tolerability data for atacicept in patients with IgAN that completed Vera trial investigating atacicept in IgAN population.
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Brazilian diabetes prevention program aims to stop type 2 diabetes before it starts
Prevention Recruiting nowThe aim of this multicenter, randomized controlled trial is to assess the effectiveness of the Brazilian Diabetes Prevention Program (delivered face-to-face or via e-health) in preventing type 2 diabetes (T2D) in at least 1,305 adults at high risk of T2D over a 3-year follow-up p…
Phase: NA • Sponsor: Beneficência Portuguesa de São Paulo • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Blood test could guide who needs extra cancer therapy after lung surgery
Disease control Recruiting nowThis study aims to incorporate circulating tumor DNA (ctDNA)-minimal residual disease (MRD) to personalize the administration of consolidation toripalimab therapy in resected stage IB-IIIA non-small-cell lung cancer (NSCLC) after adjuvant therapy. Toripalimab is a humanized monoc…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New daily pill could stop painful swelling attacks for HAE patients
Disease control OngoingThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once-daily orally administered deucrictibant extended-release tablet compared to placebo for prophylaxis to prevent angioedema attacks in participants aged ≥ …
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Magic mushroom compound shows promise for depression in new trial
Symptom relief CompletedThis randomized controlled clinical trial evaluates the effectiveness of psilocybin and psilocybin-assisted cognitive behavioral therapy (CBT) in the management of Major Depressive Disorder (MDD). The study aims to compare the effects of psilocybin-only therapy, CBT, and psilocyb…
Phase: PHASE2 • Sponsor: Khyber Medical University Peshawar • Aim: Symptom relief
Last updated Jun 26, 2026 12:50 UTC
-
New hope for rare skin cancer: drug combo trial launches
Disease control Recruiting nowCutaneous angiosarcoma is a rare cancer for which effective treatment has not been developed sufficiently. Still, because it often occurs in elderly people, the number of patients is increasing due to the aging population. Cutaneous angiosarcoma is difficult to completely remove …
Phase: PHASE2 • Sponsor: National Cancer Center, Japan • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Zapping the brain without surgery: a new hope for Tough-to-Treat epilepsy
Disease control Recruiting nowThis single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Gut bacteria test could revolutionize colon cancer screening
Diagnosis Recruiting nowColorectal cancer (CRC) is one of the most common cancer and cause of cancer death worldwide. Population-based screening programs for average-risk populations have proven effective in reducing both incidence and mortality of CRC through early detection of cancer. The fecal immuno…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New combo therapy shows promise in preventing stroke worsening
Disease control CompletedThis study is an investigator-initiated, multicenter, prospective, open-label, endpoint-blinded, randomized controlled trial (PROBE design) that includes patients with moderate or severe symptomatic intracranial large vessel atherosclerotic stenosis (sICAS) who present with acute…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common diabetes drug ease muscle problems in Steinert's disease?
Symptom relief Recruiting nowThe study team hypothesize that non-diabetic patients with Myotonic dystrophy type I (DM1) will improve their symptoms, especially their motor deficit which is the main feature of the disease, because of the splicing defect correction by metformin. The primary objective of the s…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy aims to stop liver cancer recurrence in High-Risk patients
Disease control Recruiting nowTo assess 1-year recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) who are at high risk of Inguinal orchiectomy recurrence usingTACE combined with icaritin
Phase: PHASE2, PHASE3 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC